Bleichroeder’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.29M Hold
200,000
– – 0.23% 61
2026
Q2
$1.88M Hold
200,000
– – 0.34% 36
2026
Q1
$358K Hold
200,000
– – 0.06% 53
2025
Q4
$188K Hold
200,000
– – 0.03% 56
2025
Q3
$60K Hold
200,000
– – 0.01% 63
2025
Q2
$52.5K Hold
200,000
– – 0.01% 64
2025
Q1
$7.6K Hold
200,000
– – ﹤0.01% 75
2024
Q4
$36K Hold
200,000
– – 0.01% 66
2024
Q3
$28K Hold
200,000
– – 0.01% 64
2024
Q2
$20.4K Hold
200,000
– – 0.01% 67
2024
Q1
$36.5K Hold
200,000
– – 0.01% 64
2023
Q4
$66K Buy
+200,000
New +$89.3K 0.01% 57

Other funds holding RVMDW

Bleichroeder's RVMDW Position: Q3 2026 in Review

Bleichroeder held its Revolution Medicines Inc Warrant (RVMDW) position steady in Q3 2026 at 200,000 shares worth $2.29M. The position accounts for 0.23% of the portfolio, ranked #61.

Bleichroeder first reported a position in RVMDW in Q4 2023 and has held it in 12 quarters since. 8 funds tracked by Wall St. Rank hold RVMDW as of Q3 2026.

  • Bleichroeder held 200,000 shares of Revolution Medicines Inc Warrant worth $2.29M as of Q3 2026.
  • Bleichroeder left its Revolution Medicines Inc Warrant share count unchanged in Q3 2026.
  • Revolution Medicines Inc Warrant made up 0.23% of Bleichroeder's portfolio in Q3 2026, its #61 holding.
  • Bleichroeder first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and has held it in 12 quarters since.
  • 8 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q3 2026.

Based on Bleichroeder's 13F filing for Q3 2026, filed 13 Nov 2026.